Literature DB >> 8036512

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.

S W Rogers1, P I Andrews, L C Gahring, T Whisenand, K Cauley, B Crain, T E Hughes, S F Heinemann, J O McNamara.   

Abstract

Rasmussen's encephalitis is a progressive childhood disease of unknown cause characterized by severe epilepsy, hemiplegia, dementia, and inflammation of the brain. During efforts to raise antibodies to recombinant glutamate receptors (GluRs), behaviors typical of seizures and histopathologic features mimicking Rasmussen's encephalitis were found in two rabbits immunized with GluR3 protein. A correlation was found between the presence of Rasmussen's encephalitis and serum antibodies to GluR3 detected by protein immunoblot analysis and by immunoreactivity to transfected cells expressing GluR3. Repeated plasma exchanges in one seriously ill child transiently reduced serum titers of GluR3 antibodies, decreased seizure frequency, and improved neurologic function. Thus, GluR3 is an autoantigen in Rasmussen's encephalitis, and an autoimmune process may underlie this disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036512     DOI: 10.1126/science.8036512

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  104 in total

1.  LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.

Authors:  E Koustova; Y Sei; L Fossom; M L Wei; P N Usherwood; N B Keele; M A Rogawski; A S Basile
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Utility of Tc 99m HMPAO SPECT in the early diagnosis of Rasmussen's syndrome.

Authors:  F Paladin; G Capovilla; A Bonazza; R Mameli
Journal:  Ital J Neurol Sci       Date:  1998-08

Review 3.  Future prospects for the drug treatment of epilepsy.

Authors:  A Nicolson; J P Leach
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 4.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 5.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

Review 6.  Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Authors:  Emilia H Moscato; Ankit Jain; Xiaoyu Peng; Ethan G Hughes; Josep Dalmau; Rita J Balice-Gordon
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

7.  Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.

Authors:  Katayun Cohen-Kashi Malina; Yonatan Ganor; Mia Levite; Vivian I Teichberg
Journal:  Neurochem Res       Date:  2006-09-12       Impact factor: 3.996

Review 8.  Ion channels in genetic and acquired forms of epilepsy.

Authors:  Holger Lerche; Mala Shah; Heinz Beck; Jeff Noebels; Dan Johnston; Angela Vincent
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

9.  Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.

Authors:  Makoto Hara; Eugenia Martinez-Hernandez; Helena Ariño; Thais Armangué; Marianna Spatola; Mar Petit-Pedrol; Albert Saiz; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2018-03-16       Impact factor: 9.910

10.  Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies.

Authors:  M A Farrell; O Droogan; D L Secor; V Poukens; B Quinn; H V Vinters
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.